Pathfinder 2 Study
Join the Pathfinder 2 Study with Henry Ford Health to find cancer early!
Help improve early cancer detection
Too often, cancer goes undetected until it is at an advanced stage and harder to treat. The fear and worry about the possibility of having cancer can feel debilitating. Therefore, taking steps to find cancer early can help you feel more in control of your health. Earlier detection of cancer will also improve the chance of survival and quality of life.
A blood test designed to detect multiple types of cancer
The PATHFINDER 2 Study will test the performance of a multi-cancer early detection test, called Galleri®. The test can detect many types of cancer through a simple blood draw.
This test is being studied and is not approved or cleared by the Food and Drug Administration (FDA). It is not meant to replace the cancer screening tests your healthcare provider may recommend, such as colonoscopy or mammography.
Henry Ford Health is a national study site
Henry Ford Health system will participate in this nationwide study selected by GRAIL, Inc., with the aim to improve early cancer detection.
Overseeing the study locally from our medical team:
Henry Ford Health sites that are open for participant enrollment include:
 |
Henry Ford Cancer Institute2800 W Grand Blvd, Detroit, MI 48202 |
 |
Henry Ford Hematology Oncology43630 Hayes Rd, Suite 200, Clinton Township, MI 48038 |
 |
Henry Ford Medical Center - Detroit Northwest7800 Outer Drive W, Detroit, MI 48235 |
 |
Henry Ford Medical Center - Harbortown3370 E Jefferson Ave, Detroit, MI 48207 |
Who can enroll in the Study?
The PATHFINDER 2 Study is currently open to those who:
- Are 50 years or older who receive care at Henry Ford Health
- Have never been diagnosed with cancer
- Or have been cancer-free at least three years
- And are not participants in previous or ongoing GRAIL sponsored studies
Are you eligible to enroll?
To see if you are eligible to enroll, please contact:
PATHFINDER 2 Study Team
Phone: (888) 831-4888
Email: [email protected]
What can a participant expect?
To participate in the PATHFINDER 2 Study, you will be asked to:
- Contact the study team to determine whether you are eligible to enroll.
- If eligible, read and sign an informed consent form that fully explains the study.
- Provide your medical history and allow Henry Ford Health team to access your medical records.
- Give a blood sample (40 mL) drawn by a trained staff at Henry Ford Health
- Complete a questionnaire around the time of receiving the Galleri test.
- Expect to receive your Galleri test result from the study team within 30 days after your blood is drawn.
- Complete 2-3 additional questionnaires during the follow-up period.
If you choose to participate in the PATHFINDER 2 Study, it is important that you continue to follow your healthcare provider’s recommendations for any cancer screening tests, such as colonoscopy or mammography. Missing recommended screening or ignoring symptoms could lead to a delayed diagnosis of cancer.
How to enroll
To enroll contact a study coordinator at Henry Ford Health:
Email: [email protected]